Vimarsana
Biggest News Aggregation in the World

Page 8 - Olid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Olid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Olid Today - Breaking & Trending Today

Solid operating results in a challenging market environment - adhoc - Börsennachrichten - Vimarsana News

Solid operating results in a challenging market environment - adhoc - Börsennachrichten

Zug Estates Holding AG Key word Half Year ResultsReal Estate Solid operating results in a challenging market environment 25Aug2023 0630 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR

EQS-Adhoc: Majorel Group Luxembourg S.A. : Majorel delivers solid results for H1 2023 - adhoc - Börsennachrichten - Vimarsana News

EQS-Adhoc: Majorel Group Luxembourg S.A. : Majorel delivers solid results for H1 2023 - adhoc - Börsennachrichten

EQSAdhoc Majorel Group Luxembourg SA Key word Half Year ResultsHalf Year Results Majorel Group Luxembourg SA Majorel delivers solid results for H1 2023 24Aug2023 0800 CETCEST Disclosure of an inside

PSP Swiss Property achieved a solid operating result. Improved ebitda guidance for FY 2023. - adhoc - Börsennachrichten - Vimarsana News

PSP Swiss Property achieved a solid operating result. Improved ebitda guidance for FY 2023. - adhoc - Börsennachrichten

PSP Swiss Property AG Key word Half Year Results PSP Swiss Property achieved a solid operating result Improved ebitda guidance for FY 2023 18Aug2023 0630 CETCEST Release of an ad hoc announcement pur

Gurit reports solid net sales of CHF 244.6 million in the first half of 2023 and an improved profitability - adhoc - Börsennachrichten - Vimarsana News

Gurit reports solid net sales of CHF 244.6 million in the first half of 2023 and an improved profitability - adhoc - Börsennachrichten

Gurit Holding AG Key word Half Year ResultsInterim Report Gurit reports solid net sales of CHF 2446 million in the first half of 2023 and an improved profitability 16Aug2023 0650 CETCEST Release of a

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy - Vimarsana News

Astellas and Poseida Therapeutics Announce Strategic Investment to Support Poseida's Commitment to Redefining Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic engineering technologies Astellas to invest a total of $50 million to acquire approximately 8.8% of Poseida and to receive a right of exclusive negotiation and first refusal for any potential partnering of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy product candidate for solid tumors Astellas will have the right to designate an obser...